|
1
|
Glastonbury CM: Head and neck squamous
cell cancer: Approach to staging and surveillance. Diseases of the
Brain, Head and Neck, Spine 2020–2023: Diagnostic Imaging
[Internet]. Hodler J, Kubik-Huch RJ and von Schulthess GK: Cham
(CH): Springer. Chapter 17. 2020, View Article : Google Scholar
|
|
2
|
Bray F, Ferlay J, Soerjomataram I, Siegel
RL, Torre LA and Jemal A: Global cancer statistics 2018: GLOBOCAN
estimates of incidence and mortality worldwide for 36 cancers in
185 countries. CA Cancer J Clin. 68:394–424. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Chen YP, Chan ATC, Le QT, Blanchard P, Sun
Y and Ma J: Nasopharyngeal carcinoma. Lancet. 394:64–80. 2019.
View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Lee HM, Okuda KS, González FE and Patel V:
Current perspectives on nasopharyngeal carcinoma. Adv Exp Med Biol.
1164:11–34. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Sun XS, Li XY, Chen QY, Tang LQ and Mai
HQ: Future of radiotherapy in nasopharyngeal carcinoma. Br J
Radiol. 92:92019. View Article : Google Scholar
|
|
6
|
Caponigro F, Longo F, Ionna F and Perri F:
Treatment approaches to nasopharyngeal carcinoma: A review.
Anticancer Drugs. 21:471–477. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Chen MH, Chen XJ, Wang M, Lin LG and Wang
YT: Ophiopogon japonicus-A phytochemical, ethnomedicinal and
pharmacological review. J Ethnopharmacol. 181:193–213. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Zhang W, Zhang Q, Jiang Y, Li F and Xin H:
Effects of ophiopogonin B on the proliferation and apoptosis of
SGC-7901 human gastric cancer cells. Mol Med Rep. 13:4981–4986.
2016. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Gao GY, Ma J, Lu P, Jiang X and Chang C:
Ophiopogonin B induces the autophagy and apoptosis of colon cancer
cells by activating JNK/c-Jun signaling pathway. Biomed
Pharmacother. 108:1208–1215. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Hu C, Jiang R, Cheng Z, Lu Y, Gu L, Li H,
Li L, Gao Q, Chen M and Zhang X: Ophiopogonin-B Suppresses
Epithelial-mesenchymal transition in human lung adenocarcinoma
cells via the Linc00668/miR-432-5p/EMT axis. J Cancer.
10:2849–2856. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Chen M, Hu C, Guo Y, Jiang R, Jiang H,
Zhou Y, Fu H, Wu M and Zhang X: Ophiopogonin B suppresses the
metastasis and angiogenesis of A549 cells in vitro and in
vivo by inhibiting the EphA2/Akt signaling pathway. Oncol Rep.
40:1339–1347. 2018.PubMed/NCBI
|
|
12
|
Chen M, Du Y, Qui M, Wang M, Chen K, Huang
Z, Jiang M, Xiong F, Chen J, Zhou J, et al: Ophiopogonin B-induced
autophagy in non-small cell lung cancer cells via inhibition of the
PI3K/Akt signaling pathway. Oncol Rep. 29:430–436. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Pan D: The hippo signaling pathway in
development and cancer. Dev Cell. 19:491–505. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Zhang Y, Wang M, Xu X, Liu Y and Xiao C:
Matrine promotes apoptosis in SW480 colorectal cancer cells via
elevating MIEF1-related mitochondrial division in a manner
dependent on LATS2-Hippo pathway. J Cell Physiol. 234:22731–22741.
2019. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Kim SH, Jin H, Meng RY, Kim DY, Liu YC,
Chai OH, Park BH and Kim SM: Activating hippo pathway via Rassf1 by
ursolic acid suppresses the tumorigenesis of gastric cancer. Int J
Mol Sci. 20:47092019. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Wang L, Wang J, Cao Y, Li W, Wang Y, Xu J
and Xu G: Molecular evidence for better efficacy of hypocrellin A
and oleanolic acid combination in suppression of HCC growth. Eur J
Pharmacol. 842:281–290. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Zhu Y, He D, Bo H, Liu Z, Xiao M, Xiang L,
Zhou J, Liu Y, Liu X, Gong L, et al: The MRVI1-AS1/ATF3 signaling
loop sensitizes nasopharyngeal cancer cells to paclitaxel by
regulating the Hippo-TAZ pathway. Oncogene. 38:6065–6081. 2019.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Wu RW, Chu ES, Huang Z, Xu CS, Ip CW and
Yow CM: FosPeg® PDT alters the EBV miRNAs and LMP1
protein expression in EBV positive nasopharyngeal carcinoma cells.
J Photochem Photobiol B. 127:114–122. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Chong SJ, Low IC and Pervaiz S:
Mitochondrial ROS and involvement of Bcl-2 as a mitochondrial ROS
regulator. Mitochondrion. 19:39–48. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Lu Z, Wang H, Zhu M, Song W, Wang J, Wu C,
Kong Y, Guo J, Li N, Liu J, et al: Ophiopogonin D', a natural
product from radix ophiopogonis, induces in vitro and in vivo
RIPK1-dependent and caspase-independent apoptotic death in
androgen-independent human prostate cancer cells. Front Pharmacol.
9:4322018. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Hassan M, Watari H, AbuAlmaaty A, Ohba Y
and Sakuragi N: Apoptosis and molecular targeting therapy in
cancer. Biomed Res Int. 2014:1508452014. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Crowley LC and Waterhouse NJ: Detecting
cleaved caspase-3 in apoptotic cells by flow cytometry. Cold Spring
Harb Protoc. Nov 1–2016.(Epub ahead of print). doi:
10.1101/pdb.prot087312. View Article : Google Scholar
|
|
23
|
Li J, Wu Y, Wang D, Zou L, Fu C, Zhang J
and Leung GP: Oridonin synergistically enhances the anti-tumor
efficacy of doxorubicin against aggressive breast cancer via
pro-apoptotic and anti-angiogenic effects. Pharmacol Res.
146:1043132019. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Boulares AH, Yakovlev AG, Ivanova V,
Stoica BA, Wang G, Iyer S and Smulson M: Role of poly(ADP-ribose)
polymerase (PARP) cleavage in apoptosis. Caspase 3-resistant PARP
mutant increases rates of apoptosis in transfected cells. J Biol
Chem. 274:22932–22940. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Yang Y, Karakhanova S, Hartwig W, D'Haese
JG, Philippov PP, Werner J and Bazhin AV: Mitochondria and
mitochondrial ROS in cancer: Novel targets for anticancer therapy.
J Cell Physiol. 231:2570–2581. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Kocyigit A and Guler EM: Curcumin induce
DNA damage and apoptosis through generation of reactive oxygen
species and reducing mitochondrial membrane potential in melanoma
cancer cells. Cell Mol Biol. 63:97–105. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
He J, Wei W, Yang Q and Wang Y:
Phillygenin exerts in vitro and in vivo antitumor effects in
drug-resistant human esophageal cancer cells by inducing
mitochondrial-mediated apoptosis, ROS generation and inhibition of
the nuclear factor kappa B NF-κB signalling pathway. Med Sci Monit.
25:739–745. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
NavaneethaKrishnan S, Rosales JL and Lee
KY: ROS-mediated cancer cell killing through dietary
phytochemicals. Oxid Med Cell Longev. 2019:90515422019. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Tripathi SK, Rengasamy KRR and Biswal BK:
Plumbagin engenders apoptosis in lung cancer cells via caspase-9
activation and targeting mitochondrial-mediated ROS induction. Arch
Pharm Res. 43:242–256. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
He L, He T, Farrar S, Ji L, Liu T and Ma
X: Antioxidants maintain cellular redox homeostasis by elimination
of reactive oxygen species. Cell Physiol Biochem. 44:532–553. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Huang P, Feng L, Oldham EA, Keating MJ and
Plunkett W: Superoxide dismutase as a target for the selective
killing of cancer cells. Nature. 407:390–395. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Zhao M, Luo R, Liu Y, Gao L, Fu Z, Fu Q,
Luo X, Chen Y, Deng X, Liang Z, et al: miR-3188 regulates
nasopharyngeal carcinoma proliferation and chemosensitivity through
a FOXO1-modulated positive feedback loop with
mTOR-p-PI3K/AKT-c-JUN. Nat Commun. 7:113092016. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Jiang J, Huang Z, Chen X, Luo R, Cai H,
Wang H, Zhang H, Sun T and Zhang Y: Trifluoperazine activates
FOXO1-related signals to inhibit tumor growth in hepatocellular
carcinoma. DNA Cell Biol. 36:813–821. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Meng Z, Moroishi T and Guan KL: Mechanisms
of Hippo pathway regulation. Genes Dev. 30:1–17. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Dong L, Lin F, Wu W, Liu Y and Huang W:
Verteporfin inhibits YAP-induced bladder cancer cell growth and
invasion via Hippo signaling pathway. Int J Med Sci. 15:645–652.
2018. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Hsu PC, Jablons DM, Yang CT and You L:
Epidermal Growth Factor Receptor (EGFR) Pathway, Yes-Associated
Protein (YAP) and the Regulation of Programmed Death-Ligand 1
(PD-L1) in Non-Small Cell Lung Cancer (NSCLC). Int J Mol Sci.
20:38212019. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Choi W, Kim J, Park J, Lee DH, Hwang D,
Kim JH, Ashktorab H, Smoot D, Kim SY, Choi C, et al: YAP/TAZ
initiates gastric tumorigenesis via upregulation of MYC. Cancer
Res. 78:3306–3320. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Koo JH and Guan KL: Interplay between
YAP/TAZ and Metabolism. Cell Metab. 28:196–206. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
White SM, Avantaggiati ML, Nemazanyy I, Di
Poto C, Yang Y, Pende M, Gibney GT, Ressom HW, Field J, Atkins MB
and Yi C: YAP/TAZ inhibition induces metabolic and signaling
rewiring resulting in targetable vulnerabilities in NF2-deficient
tumor cells. Dev Cell. 49:425–443.e9. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Li S, Zhang X, Zhang R, Liang Z, Liao W,
Du Z, Gao C, Liu F, Fan Y and Hong H: Hippo pathway contributes to
cisplatin resistant-induced EMT in nasopharyngeal carcinoma cells.
Cell Cycle. 16:1601–1610. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Song L, Tang H, Liao W, Luo X, Li Y, Chen
T and Zhang X: FOXC2 positively regulates YAP signaling and
promotes the glycolysis of nasopharyngeal carcinoma. Exp Cell Res.
357:17–24. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Gao L, Cheng XL and Cao H: LncRNA THOR
attenuates cisplatin sensitivity of nasopharyngeal carcinoma cells
via enhancing cells stemness. Biochimie. 152:63–72. 2018.
View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Suemura S, Kodama T, Myojin Y, Yamada R,
Shigekawa M, Hikita H, Sakamori R, Tatsumi T and Takehara T: CRISPR
Loss-of-Function screen identifies the hippo signaling pathway as
the mediator of regorafenib efficacy in hepatocellular carcinoma.
Cancers. 11:13622019. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Ye XY, Luo QQ, Xu YH, Tang NW, Niu XM, Li
ZM, Shen SP, Lu S and Chen ZW: 17-AAG suppresses growth and
invasion of lung adenocarcinoma cells via regulation of the
LATS1/YAP pathway. J Cell Mol Med. 19:651–663. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Han Y, Tang Z, Zhao Y, Li Q and Wang E:
TNFAIP8 regulates Hippo pathway through interacting with LATS1 to
promote cell proliferation and invasion in lung cancer. Mol
Carcinog. 57:159–166. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Li Y, Lu J, Chen Q, Han S, Shao H, Chen P,
Jin Q, Yang M, Shangguan F, Fei M, et al: Artemisinin suppresses
hepatocellular carcinoma cell growth, migration and invasion by
targeting cellular bioenergetics and Hippo-YAP signaling. Arch
Toxicol. 93:3367–3383. 2019. View Article : Google Scholar : PubMed/NCBI
|
